Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy.

MLA

Liu, Zengyi, et al. “Tetrahydrobiopterin Inhibitor-Based Antioxidant Metabolic Strategy for Enhanced Cancer Ferroptosis-Immunotherapy.” Journal of Colloid & Interface Science, vol. 658, Mar. 2024, pp. 100–13. EBSCOhost, https://doi.org/10.1016/j.jcis.2023.12.042.

APA

Liu, Z., Kang, R., Yang, N., Pan, X., Yang, J., Yu, H., Deng, W., Jia, Z., Zhang, J., & Shen, Q. (2024). Tetrahydrobiopterin inhibitor-based antioxidant metabolic strategy for enhanced cancer ferroptosis-immunotherapy. Journal of Colloid & Interface Science, 658, 100–113. https://doi.org/10.1016/j.jcis.2023.12.042

Chicago

Liu, Zengyi, Ruixin Kang, Ning Yang, Xiuhua Pan, Jie Yang, Hongjie Yu, Wanli Deng, Zengguang Jia, Jun Zhang, and Qi Shen. 2024. “Tetrahydrobiopterin Inhibitor-Based Antioxidant Metabolic Strategy for Enhanced Cancer Ferroptosis-Immunotherapy.” Journal of Colloid & Interface Science 658 (March): 100–113. doi:10.1016/j.jcis.2023.12.042.